Enantioselective reduction of pentoxifylline to lisofylline using whole‐cell Lactobacillus kefiri biotransformation

Lisofylline (LSF) is a drug candidate that has been under investigation for acute respiratory distress syndrome, acute lung injury, septic shock and mucositis. As LSF is not commercially available in our country, we produced it for pharmacokinetic studies. In the present work whole‐cell reduction of pentoxifylline [1‐(5‐oxohexyl)‐3,5‐dimethylxanthine] to LSF [1‐(5R‐hydroxyhexyl)‐3,5‐dimethylxanthine] using Lactobacillus kefiri DSM 20587 was investigated. Glucose or 2‐propanol was used as a co‐substrate to regenerate the NADPH cofactor. The reaction conditions were optimized. The influence of different concentrations of co‐substrates on the yield and enantioselectivity of the biotransformation of pentoxifylline into LSF were tested. Maximum yield (100%) of biotransformation was reached in the presence of glucose as a co‐substrate. At glucose concentrations of 675 and 900 mM the bioreduction of pentoxifylline proceeded highly enantioselectively (enantiomeric excess for the R enantiomer of 98%).

[1]  E. Pękala,et al.  Enantioselective biotransformation of pentoxifylline into lisofylline using wine yeast biocatalysis. , 2007, Acta Poloniae Pharmaceutica - Drug Research.

[2]  M. Gelo-Pujic,et al.  Microbial and homogenous asymmetric catalysis in the reduction of 1-[3,5-bis(trifluoromethyl)phenyl]ethanone , 2006 .

[3]  C. Wandrey,et al.  Synthesis of enantiopure (5R)-hydroxyhexane-2-one with immobilised whole cells of Lactobacillus kefiri , 2006, Applied Microbiology and Biotechnology.

[4]  W. Hummel,et al.  Cloning, expression, and characterization of an (R)-specific alcohol dehydrogenase from Lactobacillus kefir , 2006 .

[5]  E. Wyska,et al.  Interconversion and tissue distribution of pentoxifylline and lisofylline in mice. , 2006, Chirality.

[6]  D. Weuster‐Botz,et al.  Asymmetric synthesis of the chiral synthon ethyl (S)-4-chloro-3-hydroxybutanoate using Lactobacillus kefir , 2005 .

[7]  D. Weuster‐Botz,et al.  Asymmetric synthesis of tert-butyl (3R, 5S) 6-chloro-dihydroxyhexanoate with Lactobacillus kefir , 2005, Applied Microbiology and Biotechnology.

[8]  W. Hummel.  Enzyme-catalyzed synthesis of optically pure R(+)-phenylethanol , 1990, Biotechnology Letters.

[9]  Meng Chen,et al.  Lisofylline: a potential lead for the treatment of diabetes. , 2005, Biochemical pharmacology.

[10]  D. Weuster‐Botz,et al.  Production of Lactobacillus kefir cells for asymmetric synthesis of a 3,5-dihydroxycarboxylate , 2005, Applied Microbiology and Biotechnology.

[11]  H. Sahm,et al.  Enantioselective reduction of carbonyl compounds by whole-cell biotransformation, combining a formate dehydrogenase and a (R)-specific alcohol dehydrogenase , 2005, Applied Microbiology and Biotechnology.

[12]  W. Kroutil,et al.  Recent advances in the biocatalytic reduction of ketones and oxidation of sec-alcohols. , 2004, Current opinion in chemical biology.

[13]  W. Hummel.  Reduction of acetophenone to R(+)-phenylethanol by a new alcohol dehydrogenase from Lactobacillus kefir , 1990, Applied Microbiology and Biotechnology.

[14]  C. Wandrey.  Biochemical reaction engineering for redox reactions. , 2004, Chemical record.

[15]  Huimin Zhao,et al.  Regeneration of cofactors for use in biocatalysis. , 2003, Current opinion in biotechnology.

[16]  T. Matsuda,et al.  Recent developments in asymmetric reduction of ketones with biocatalysts , 2003 .

[17]  Huimin Zhao,et al.  Recent developments in pyridine nucleotide regeneration. , 2003, Current opinion in biotechnology.

[18]  M. Kataoka,et al.  Novel bioreduction system for the production of chiral alcohols , 2003, Applied Microbiology and Biotechnology.

[19]  A. Liese,et al.  Diastereoselective synthesis of optically active (2R,5R)-hexanediol , 2002, Applied Microbiology and Biotechnology.

[20]  T. Matsuda,et al.  Chiral synthesis of secondary alcohols using Geotrichum candidum. , 2002, Chirality.

[21]  J. B. Arterburn.  Selective oxidation of secondary alcohols , 2001 .

[22]  Ramesh N. Patel,et al.  Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances. , 2001, Current opinion in biotechnology.

[23]  A. Kiener,et al.  Industrial biocatalysis today and tomorrow , 2001, Nature.

[24]  C. Coleman,et al.  Lisofylline as a modifier of radiation therapy. , 1996, Oncology research.

[25]  R. Shenkar,et al.  Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice , 1995, The Journal of experimental medicine.

[26]  Chi‐Huey Wong,et al.  Lactobacillus kefir alcohol dehydrogenase: a useful catalyst for synthesis , 1992 .

[27]  M. Kataoka,et al.  A novel NADPH-dependent aldehyde reductase, catalyzing asymmetric reduction of ß-keto acid esters, from Sporobolomyces salmonicolor: purification and characterization , 1990 .

[28]  E. Keinan,et al.  Synthetic Applications of Alcohol‐Dehydrogenase from Thermoanaerobium brockii a , 1987 .

[29]  E. Keinan,et al.  Thermostable enzymes in organic synthesis. 2. Asymmetric reduction of ketones with alcohol dehydrogenase from Thermoanaerobium brockii , 1986 .

[30]  C. Sih,et al.  Microbial Asymmetric Catalysis—Enantioselective Reduction of Ketones [New Synthetic Methods (45)] , 1984 .

[31]  D. Seebach,et al.  Preparative Microbial Reduction of β‐Oxoesters with Thermoanaerobium brockii , 1984 .

[32]  V. Prelog.  Specification of the stereospecificity of some oxido-reductases by diamond lattice sections , 1964 .